Abstract

Collagen cross-linking (CXL) is a new horizon in the treatment of corneal diseases.The corneal stroma is the thickest part of the cornea and is mainly composed of collagen fibrils,charged with stromal maintenance and wound healing. CXL by using UV rays and riboflavin could actas a photo mediator to inactivate pathogens in plasma, platelets, and red blood cells. Riboflavin alsoinduces a change in properties of the collagen and has a stiffening effect on the corneal stroma,which stabilizes it and increases its resistance to enzymatic bacteria degradation avoiding theprogression of corneal melting this study aimed to assess the efficacy and safety of corneal collagencross-linking (CXL) in the management of infectious keratitis.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.